PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Moderate dose radiotherapy effective in EORTC trial for patients with desmoid-type fibromatosis

2013-07-18
(Press-News.org) A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.

Dr. Ronald B. Keus, Arnhem Radiotherapy Institute in The Netherlands and Coordinator of this study says, "Although one should still be cautious to use radiotherapy in these young patients, it is important to have shown sound proof of efficacy of radiotherapy in this disease."

Desmoid-type fibromatosis, a rare form of cancer, is a soft tissue neoplasm that can recur frequently but is not metastatic. The survival prognosis for patients with this disease is good, but due to the frequent recurrences, the consequences of treatment can lower functional outcomes and quality of life. Desmoid-type fibromatosis strikes most frequently in persons between 30 and 40 years of age.

The first line of treatment for patients with desmoid-type fibromatosis is usually surgery, so the phase 2 EORTC 62991-22998 trial was conducted to determine if moderate doses of radiotherapy might improve outcome for patients with inoperable and progressive disease or in cases of expected extensive and mutilating surgery. The primary endpoint was local control rate at three years, and secondary endpoints were objective tumor response, acute toxicity, and late toxicity.

Dr. Winette van der Graaf of the Radboud University Medical Center, Nijmegen, The Netherlands, and Chair of the EORTC Soft Tissue and Bone Sarcoma Group says, "Desmoid- fibromatosis remains a challenge for surgeons, radiotherapists and medical oncologists. This study has generated valuable information about radiotherapy as an option for patients with desmoid-type fibromatosis which can be discussed at future multidisciplinary sarcoma tumor boards."

EORTC trial 62991-22998 enrolled 44 patients, 27 females and 17 males, between 2001 and 2008 in twelve sites located in five countries: Belgium, Germany, Poland, The Netherlands, and the United Kingdom. The median age was 39.5 years, and the main tumor sites included trunk 15 (34.1%) and extremities 27 (61.3%). At a median follow up of 4.8 years, the 3-year local control rate was 81.5%.

The best overall response during the first three years was: complete response in six patients (13.6%); partial response in 16 patients (36.4%); stable disease in 18 patients (40.9%); progressive disease in three patients (6.8%). One patient (2.3%) was non-assessable.

After three years two patients improved to complete response and one patient improved to partial response. Five patients developed new lesions during the study, and ten patients experienced mild edema as a late toxicity. Acute grade 3 side effects were limited to skin, mucosal membranes and pain.

### EORTC 62991-22998 was coordinated by the EORTC Soft Tissue and Bone Sarcoma Group in collaboration with the EORTC Radiation Oncology Group. This trial was supported by FOCA.


ELSE PRESS RELEASES FROM THIS DATE:

New methods to visualize bacterial cell-to-cell communication

2013-07-18
Most bacteria are able to communicate with each other by secreting signaling molecules. Once the concentration of signals has reached a critical density («the Quorum), the bacteria are able to coordinate their behavior. Only when this critical population density has been reached certain genes are activated that lead to, for example, the formation of biofilms or the expression of virulence factors. Bacteria utilize this so-called «Quorum Sensing» (QS) to synchronize their behavior to regulate functions that benefit the entire population. The most commonly used signaling ...

Study demonstrates link between reclassification of cannabis and cannabis psychosis

2013-07-18
Researchers from the University of York have demonstrated that the change in cannabis declassification in 2009 has coincided with a significant increase in hospital admissions for cannabis psychosis - rather than the decrease it was intended to produce. The UK Misuse of Drugs Act (1971) divided controlled drugs into three groups – A, B and C – with descending criminal sanctions attached to each class. Cannabis was originally assigned to Group B, but in 2004, it was transferred to the lowest risk group, Group C. In 2009, on the basis of increasing concerns about a link ...

Spanish scientists successfully generate 'artificial bones' from umbilical cord stem cells

2013-07-18
Scientists in Granada, Spain, have patented a new biomaterial that facilitates generating bone tissue—artificial bones in other words—from umbilical cord stem cells . The material, consisting of an activated carbon cloth support for cells that differentiate giving rise to a product that can promote bone growth, has recently been presented at a press conference at the Biomedical Research Centre, Granada. Although the method has not yet been applied with 'in vivo' models, laboratory results are highly promising. In the future, they could help manufacture medicines for the ...

Newly found CLAMP protein regulates genes

2013-07-18
PROVIDENCE, R.I. [Brown University] — They say a good man is hard to find. Were it not for a newly discovered protein, the X chromosome of a male fruit fly could never be found by a gene-regulating complex that male flies need to develop and survive. And that case is just one example of what the new finding means. More generally, the research provides biologists with a model of how proteins that govern gene transcription find their targets on chromosomes, a process that's essential to healthy cell function and sometimes implicated in disease. The new protein, dubbed CLAMP ...

Milikelvins drive droplet evaporation

2013-07-18
Evaporation is so common that everybody thinks it's a well understood phenomenon. Appearances can be, however, deceptive. Recently, a new, earlier not predicted mechanism of evaporation was discovered. Experiments and simulations performed at the Institute of Physical Chemistry of the Polish Academy of Sciences and the Institute of Physics of the PAS not only confirm its existence, but also indicate that it plays the crucial role in evaporation process in the nanoscale. Too hot? It's not only because of summer. It's also likely that the sweat on your skin stopped to evaporate ...

Biochemical mapping helps explain who will respond to antidepressants

2013-07-18
DURHAM, N.C. -- Duke Medicine researchers have identified biochemical changes in people taking antidepressants – but only in those whose depression improves. These changes occur in a neurotransmitter pathway that is connected to the pineal gland, the part of the endocrine system that controls the sleep cycle, suggesting an added link between sleep, depression and treatment outcomes. The study, published on July 17, 2013, in the journal PLOS ONE, uses an emerging science called pharmacometabolomics to measure and map hundreds of chemicals in the blood in order to define ...

Infection biology: How Legionella subverts to survive

2013-07-18
Bacteria of the genus Legionella have evolved a sophisticated system to replicate in the phagocytic cells of their hosts. Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have now identified a novel component of this system. In humans, Legionella is responsible for the so-called Legionnaires' disease, a form of bacterial pneumonia that is often lethal. The bacteria can also cause Pontiac fever, a flu-like condition characterized by coughing and vomiting. Most Legionella-associated illnesses in humans are caused by Legionella pneumophila. These microorganisms ...

Avocado farmers face unique foe in fungal-farming beetle

2013-07-18
Beetles with unusual "green thumbs" for growing fungi are threatening avocado crops and could transform into a more destructive pest, according to an international team of researchers. Ambrosia beetles are insects that bore into trees and cultivate fungi to use as a food source for their young. The fungi -- species of Fusarium -- carried by types of the Ambrosia beetle can damage or even kill trees, making the beetle and its fungi a threat to avocado production in the U.S. and Israel, according to Matthew Kasson, who recently received his doctorate in forest pathology ...

Cancer 'prehabilitation' can reduce complications and improve treatment outcomes

2013-07-18
Philadelphia, Pa. (July 18, 2013) - For patients with cancer, "prehabilitation"— interventions given between the time of diagnosis and the start of treatment—has the potential to reduce complications from treatments and improve physical and mental health outcomes, according to a report in the August American Journal of Physical Medicine & Rehabilitation (AJPM&R). AJPM&R, the official journal of the Association of Academic Physiatrists, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. "A growing body of evidence supports preparing newly diagnosed ...

Stanford scientists break record for thinnest light-absorber

2013-07-18
Stanford University scientists have created the thinnest, most efficient absorber of visible light on record. The nanosize structure, thousands of times thinner than an ordinary sheet of paper, could lower the cost and improve the efficiency of solar cells, according to the scientists. Their results are published in the current online edition of the journal Nano Letters. "Achieving complete absorption of visible light with a minimal amount of material is highly desirable for many applications, including solar energy conversion to fuel and electricity," said Stacey Bent, ...

LAST 30 PRESS RELEASES:

Fatty muscles raise the risk of serious heart disease regardless of overall body weight

HKU ecologists uncover significant ecological impact of hybrid grouper release through religious practices

New register opens to crown Champion Trees across the U.S.

A unified approach to health data exchange

New superconductor with hallmark of unconventional superconductivity discovered

Global HIV study finds that cardiovascular risk models underestimate for key populations

New study offers insights into how populations conform or go against the crowd

Development of a high-performance AI device utilizing ion-controlled spin wave interference in magnetic materials

WashU researchers map individual brain dynamics

Technology for oxidizing atmospheric methane won’t help the climate

US Department of Energy announces Early Career Research Program for FY 2025

PECASE winners: 3 UVA engineering professors receive presidential early career awards

‘Turn on the lights’: DAVD display helps navy divers navigate undersea conditions

MSU researcher’s breakthrough model sheds light on solar storms and space weather

Nebraska psychology professor recognized with Presidential Early Career Award

New data shows how ‘rage giving’ boosted immigrant-serving nonprofits during the first Trump Administration

Unique characteristics of a rare liver cancer identified as clinical trial of new treatment begins

From lab to field: CABBI pipeline delivers oil-rich sorghum

Stem cell therapy jumpstarts brain recovery after stroke

Polymer editing can upcycle waste into higher-performance plastics

Research on past hurricanes aims to reduce future risk

UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology

Panorama of our nearest galactic neighbor unveils hundreds of millions of stars

A chain reaction: HIV vaccines can lead to antibodies against antibodies

Bacteria in polymers form cables that grow into living gels

Rotavirus protein NSP4 manipulates gastrointestinal disease severity

‘Ding-dong:’ A study finds specific neurons with an immune doorbell

A major advance in biology combines DNA and RNA and could revolutionize cancer treatments

Neutrophil elastase as a predictor of delivery in pregnant women with preterm labor

NIH to lead implementation of National Plan to End Parkinson’s Act

[Press-News.org] Moderate dose radiotherapy effective in EORTC trial for patients with desmoid-type fibromatosis